0001209191-19-053541.txt : 20191017
0001209191-19-053541.hdr.sgml : 20191017
20191017201535
ACCESSION NUMBER: 0001209191-19-053541
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191015
FILED AS OF DATE: 20191017
DATE AS OF CHANGE: 20191017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weiss Patrick
CENTRAL INDEX KEY: 0001755793
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 191156492
MAIL ADDRESS:
STREET 1: C/O TWIST BIOSCIENCE CORPORATION
STREET 2: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-15
1
0001581280
Twist Bioscience Corp
TWST
0001755793
Weiss Patrick
C/O TWIST BIOSCIENCE CORPORATION
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO
CA
94158
0
1
0
0
SVP, R&D GM Data Storage
Common Stock
2019-10-15
4
M
0
3702
5.95
A
108989
D
Common Stock
2019-10-15
4
M
0
3662
8.82
A
112651
D
Common Stock
2019-10-15
4
S
0
40
22.82
D
112611
D
Common Stock
2019-10-15
4
S
0
3662
23.335
D
108949
D
Common Stock
2019-10-15
4
S
0
3662
23.342
D
105287
D
Common Stock
2019-10-16
4
M
0
3682
5.95
A
108969
D
Common Stock
2019-10-16
4
M
0
3682
8.82
A
112651
D
Common Stock
2019-10-16
4
S
0
1872
23.578
D
110779
D
Common Stock
2019-10-16
4
S
0
1810
24.34
D
108969
D
Common Stock
2019-10-16
4
S
0
1884
23.593
D
107085
D
Common Stock
2019-10-16
4
S
0
1798
24.338
D
105287
D
Employee Stock Option (right to buy)
5.95
2019-10-15
4
M
0
3702
0.00
D
2025-09-28
Common Stock
3702
14617
D
Employee Stock Option (right to buy)
8.82
2019-10-15
4
M
0
3662
0.00
D
2027-09-28
Common Stock
3662
70602
D
Employee Stock Option (right to buy)
5.95
2019-10-16
4
M
0
3682
0.00
D
2025-09-28
Common Stock
3682
10935
D
Employee Stock Option (right to buy)
8.82
2019-10-16
4
M
0
3682
0.00
D
2027-09-28
Common Stock
3682
66920
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Represents the aggregate of sales effected on the same day at different prices.
Represents the weighted average sales price per share. The shares sold at prices ranging from $22.81 to $23.70 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $23.20 to $23.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $24.20 to $24.48 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $23.20 to $24.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $24.20 to $24.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
The option is immediately exercisable. 10% of the shares subject to the option vested on September 29, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
/s/ William Solis, as Attorney-in-Fact for Patrick Weiss
2019-10-17